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Abstract
AIM
To analyze colorectal carcinogenesis and age-related 
DNA methylation alterations of gene sequences 
associated with epigenetic clock CpG sites. 
METHODS
In silico  DNA methylation analysis of 353 epigenetic 
clock CpG sites published by Steve Horvath was 
performed using methylation array data for a set of 
123 colonic tissue samples [64 colorectal cancer (CRC), 
42 adenoma, 17 normal; GEO accession number: 
GSE48684]. Among the differentially methylated age-
related genes, secreted frizzled related protein 1 
(SFRP1) promoter methylation was further investigated 
in colonic tissue from 8 healthy adults, 19 normal 
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ORIGINAL ARTICLE
Aging related methylation influences the gene expression 
of key control genes in colorectal cancer and adenoma
Basic Study
Orsolya Galamb, Alexandra Kalmár, Barbara Kinga Barták, Árpád V Patai, Katalin Leiszter, Bálint Péterfia, 
Barnabás Wichmann, Gábor Valcz, Gábor Veres, Zsolt Tulassay, Béla Molnár
children, 20 adenoma and 8 CRC patients using 
bisulfite-specific PCR followed by methylation-specific 
high resolution melting (MS-HRM) analysis. mRNA 
expression of age-related “epigenetic clock” genes 
was studied using Affymetrix HGU133 Plus2.0 whole 
transcriptome data of 153 colonic biopsy samples (49 
healthy adult, 49 adenoma, 49 CRC, 6 healthy children) 
(GEO accession numbers: GSE37364, GSE10714, 
GSE4183, GSE37267). Whole promoter methylation 
analysis of genes showing inverse DNA methylation-
gene expression data was performed on 30 colonic 
samples using methyl capture sequencing. 
RESULTS
Fifty-seven age-related CpG sites including hyper-
methylated PPP1R16B , SFRP1 , SYNE1  and hypo-
methylated MGP, PIPOX were differentially methylated 
between CRC and normal tissues (P  < 0.05, ∆β ≥ 
10%). In the adenoma vs  normal comparison, 70 CpG 
sites differed significantly, including hypermethylated 
DKK3 , SDC2 , SFRP1 , SYNE1  and hypomethylated 
CEMIP , SPATA18  (P  < 0.05, ∆β ≥ 10%). In MS-HRM 
analysis, the SFRP1 promoter region was significantly 
hypermethylated in CRC (55.0% ± 8.4 %) and adenoma 
tissue samples (49.9% ± 18.1%) compared to normal 
adult (5.2% ± 2.7%) and young (2.2% ± 0.7%) colonic 
tissue (P < 0.0001). DNA methylation of SFRP1 promoter 
was slightly, but significantly increased in healthy adults 
compared to normal young samples (P  < 0.02). This 
correlated with significantly increased SFRP1  mRNA 
levels in children compared to normal adult samples (P 
< 0.05). In CRC tissue the mRNA expression of 117 age-
related genes were changed, while in adenoma samples 
102 genes showed differential expression compared 
with normal colonic tissue (P < 0.05, logFC > 0.5). The 
change of expression for several genes including SYNE1, 
CLEC3B, LTBP3 and SFRP1, followed the same pattern in 
aging and carcinogenesis, though not for all genes (e.g. , 
MGP). 
CONCLUSION
Several age-related DNA methylation alterations can 
be observed during CRC development and progression 
affecting the mRNA expression of certain CRC- and 
adenoma-related key control genes. 
Key words: DNA methylation; Aging; Colorectal cancer; 
Adenoma; Epigenetic drift; Epigenetic clock; Secreted 
frizzled related protein 1
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Several age-related DNA methylation altera-
tions could be observed during colorectal cancer 
(CRC) formation and progression affecting the mRNA 
expression of certain CRC- and adenoma-related key 
control genes such as hypermethylated secreted frizzled 
related protein 1 (SFRP1 ), spectrin repeat containing 
nuclear envelope protein 1 and hypomethylated 
cell migration-inducing protein. For the first time 
significantly lower SFRP1  methylation levels were 
demonstrated in colonic tissue from children (under 
18 years) compared to healthy adults. The main CRC-
associated signal transduction pathways, such as WNT 
signaling and PI3K/Akt pathways are also influenced 
during aging.
Galamb O, Kalmár A, Barták BK, Patai AV, Leiszter K, Péterfia 
B, Wichmann B, Valcz G, Veres G, Tulassay Z, Molnár B. Aging 
related methylation influences the gene expression of key control 
genes in colorectal cancer and adenoma. World J Gastroenterol 
2016; 22(47): 10325-10340  Available from: URL: http://www.
wjgnet.com/1007-9327/full/v22/i47/10325.htm  DOI: http://
dx.doi.org/10.3748/wjg.v22.i47.10325
INTRODUCTION
DNA methylation alterations in connection with 
aging include epigenetic drift and epigenetic clock 
phenomena. Epigenetic drift is defined as the global 
DNA methylation changes caused by random and 
environmental individual-specific factors, while the 
epigenetic clock is defined as a group of progressive 
age-related epigenetic alterations at specific geno-
mic sites which are common across individuals and 
occassionally across various tissue types[1,2]. The 
epigenetic clock concept is an approach to biological 
age prediction of different tissues based on the 
DNA methylation status of 353 CpG sites measured 
using the Illumina Beadchip450K methylation array 
platform[2]. 
Although age-related (A type) and cancer-related 
(C type) DNA methylation are often distinguished, 
the main age-related disease is cancer and the age of 
patients is one of the risk factor for carcinogenesis[3]. 
In human development, following a transient increase 
in average DNA methylation in early childhood (during 
the first year of life)[4,5], global hypomethylation 
is characteristic during aging[6,7]. Similarly global 
hypomethylation is observed in various types 
of cancers including colorectal cancer (CRC)[8]. 
With aging, besides global hypomethylation, local 
hypermethylation can occur on promoters of certain 
genes, including tumor suppressor gene promo-
ters in various types of cancers, and many tumor 
suppressor genes were reported among the age-
dependently hypermethylated genes[6]. Among others, 
promoter hypermethylation of APC[7,9-12], CDKN2A[7,9], 
ESR1[7,13,14], GATA5[15,16], HPP1[7,15,17], SFRP1[7,12,15,18-23] 
and SFRP2[7,18-21] genes was reported for colonic tissues 
during both aging and colorectal carcinogenesis. 
Although DNA methylation data from adult colonic 
tissue samples has been expansively published, data 
for children/young patients are limited. 
In this study, we analyzed DNA methylation and/or 
gene expression changes of genes covered by the 353 
epigenetic clock CpG sites[2] for patients of different 
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ages as well as stages in the progression through 
to CRC in order to study the possible relationship 
between age-related and cancer-associated epigenetic 
alterations. Gene expression analysis was performed 
using colonic tissue samples from healthy children, 
healthy adults, and patients with adenomas and CRC. 
Among the differentially methylated/expressed age-
related genes, secreted frizzled related protein 1 
(SFRP1) promoter methylation was further analyzed 
in healthy, premalignant and cancerous colonic tissue 
samples, and to our knowledge this is the first study to 
also include colonic biopsy specimens from children. 
MATERIALS AND METHODS
In silico DNA methylation analysis 
The DNA methylation status of 353 age-related 
CpG sites[2] was analyzed in silico using methylation 
array data from the Illumina BeadChip450K. 
Analysis was performed on 123 CRC, adenoma and 
normal tissue samples available in the NCBI Gene 
Expression Database database (GEO accession 
number: GSE48684[24]). Differences between average 
methylation values of the compared diagnostic groups 
(∆β-values) and P values were determined for each 
CpG site (cg IDs). For statistical evaluation, normal 
distribution was checked using Kolmogorov-Smirnov 
test. Hence normal distribution was observed in any 
cases, Student’s t-test with Benjamini and Hochberg 
correction was applied for paired group comparisons. 
Significance criteries were P < 0.05 in all cases.
In silico gene expression analysis
The expression of age-related “epigenetic clock” 
genes was analyzed using whole transcriptome data 
from Affymetrix HGU133 Plus2.0. Data was obtained 
from 153 colonic biopsy samples (49 healthy, 49 
adenoma, 49 CRC and 6 healthy children) previously 
hybridized by our research group (GEO serial accession 
numbers: GSE37364[25], GSE10714[26], GSE4183[27], 
GSE37267[28]). Gene expression levels were compared 
using unpaired Student’s t-test with Benjamini and 
Hochberg correction (P value of < 0.05 was considered 
as significant). For gene expression analysis, normal 
distribution was found using Kolmogorov-Smirnov test, 
therefore Student’s t-test (in case of differentiation 
of two groups with equal variances) or Welch-test 
(in case of differentiation of two groups with unequal 
variances) and ANOVA (when more than two groups 
were compared) were applied. For paired comparisons 
Benjamini and Hochberg correction was applied. In 
case of ANOVA, Tukey HSD post-test was used in order 
to find out which group refers to the differentiation if 
any. Significance criteries were P < 0.05 in any cases. 
For the logFC calculation, the differences between the 
averages of groups were considered (abs logFC ≥ 0.5 
criteria). 
Methyl capture sequencing - in silico data analysis
Whole methylome data from 6 normal adjacent tissue 
(NAT), 15 adenoma and 9 CRC tissue samples were 
determined in a previous study using methyl capture 
sequencing[12]. Using this dataset, the whole promoter 
methylation status of genes showing an inverse relation 
between gene expression and DNA methylation was 
evaluated. Differentially methylated genes were deter-
mined as described earlier[12]. For statistical evaluation 
normal distribution was determined and the applied 
tests were chosen according to the above-mentioned 
criteria. Differences with P < 0.05 were considered 
as significant. Methylation alterations between 
diagnostic groups were characterized by ∆β-values 
(the differences of the average β-values of sample 
groups). 
Clinical samples
All patients provided informed consent. Colorec-
tal biopsy samples were obtained during routine 
endoscopic intervention at the 2nd Department of 
Internal Medicine and 1st Department of Paediatrics, 
Semmelweis University, Budapest, Hungary. In total 55 
colonic tissue samples (from 19 healthy children (under 
age of 18 years), 8 healthy adults, 20 patients with 
adenomas and 8 CRC samples) were tested in SFRP1 
methylation-specific high resolution melting (MS-HRM) 
study (Table 1). Biopsy samples from all adults and 
5 of children were stored in RNALater Stabilization 
Solution (Ambion, ThermoFisher Scientific) at -80 ℃ 
until use. Biopsy samples from the same site were 
immediately fixed in buffered formalin for histological 
evaluation. For 14 children, only FFPE blocks were 
available. Histological diagnoses were established by 
experienced pathologists. Altogether 27 tissue samples 
(19 from children and 8 from adults) with normal 
histology (so called healthy normal colonic tissue 
samples) were involved in SFRP1 MS-HRM study. 
Children and adults in the study had been referred to 
the outpatient clinic with rectal bleeding, constipation 
or chronic abdominal pain. Ileocolonoscopy was part 
of their diagnostic procedure (exclude organic disease) 
and the biopsy specimens showed normal macroscopic 
appearance and histology[28]. The study was conducted 
according to the Helsinki declaration and approved by 
the local ethics committee and government authorities 
(Regional and Institutional Committee of Science and 
Research Ethics (TUKEB) Nr.: 69/2008, 202/2009 
and 23970/2011 Semmelweis University, Budapest, 
Hungary).
DNA isolation
Tissue samples were homogenized in 2% sodium 
dodecyl sulphate, and digested with 4 mg/mL proteinase 
K for 16 h at 56 ℃. Genomic DNA was isolated using the 
High Pure PCR Template Preparation Kit (Roche Applied 
Science) according to the manufacturer’s instructions[18]. 
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Table 1  Clinical data of samples involved in the high resolution melting study
Sample 
ID
Age Gender Localization Histology TNM Grade Dukes’ stage 
(MAC)
Dysplasia Adenoma size Sample type
Ch1   4 M Colon Normal FFPE
Ch2   7 F Cecum Normal FFPE
Ch3 11 M Colon Normal FFPE
Ch4 14 M Transverse Normal FFPE
Ch5   5 F Sigmoid Normal FFPE
Ch6   7 F Descendent Normal FFPE
Ch7   1 M Descendent Normal FFPE
Ch8   1 M Sigmoid Normal FFPE
Ch9 10 M Cecum Normal FFPE
Ch10   3 M Sigmoid Normal FFPE
Ch11 17 F Cecum Normal FFPE
Ch12 17 F Sigmoid Normal FFPE
Ch13 16 F Sigmoid Normal FFPE
Ch14 16 F Cecum Normal FFPE
Ch15   1 M Left colon Normal FF
Ch16   3 F Sigmoid Normal FF
Ch17   6 M Sigmoid Normal FF
Ch18   9 M Sigmoid Normal FF
Ch19 17 M Colon Normal FF
N1 44 F Sigmoid Normal FF
N2 31 F Sigmoid Normal FF
N3 59 F Sigmoid Normal FF
N4 54 M Colon Normal FF
N5 68 F Sigmoid Normal FF
N6 71 F Sigmoid Normal FF
N7 69 F Sigmoid Normal FF
N8 57 F Sigmoid Normal FF
AD1 78 M Asc, sigmoid, 
rectum
Tubulovillous 
adenoma
Low-grade 30 mm, 3 mm, 
15 mm
FF
AD2 60 M Sigmoid Tubular 
adenoma
Low-grade 6 mm FF
AD3 88 M Asc, transv, 
sigmoid
Tubular 
adenoma
Low-grade 4 mm, 3 mm, 7-8 
mm
FF
AD4 72 F Rectum Tubular 
adenoma
Low-grade 10 mm FF
AD5 45 F Descendent Tubular 
adenoma
High-grade 5-6 mm FF
AD6 68 F Rectum Tubular 
adenoma
Low-grade 5 mm FF
AD7 63 F Sigmoid Tubular 
adenoma
Low-grade 8 mm FF
AD8 65 F Asc, transv, 
rectum
Tubular 
adenoma
Low-grade 2-3 mm, 2-3 mm, 
2-3 mm
FF
AD9 60 F Sigmoid Tubular 
adenoma
Low-grade 5 mm, 4 mm FF
AD10 77 F Rectosigmoid Tubular 
adenoma
Low-grade 5 mm FF
AD11 55 F Asc colon Tubular 
adenoma
Low-grade 10 mm FF
AD12 76 M Cecum, sigmoid Tubular 
adenoma
Low-grade 5 mm, 8-10 mm FF
AD13 62 F Sigmoid Tubular 
adenoma
High-grade 30 mm FF
AD14 83 M Asc colon Tubulovillous 
adenoma
High-grade 50-60 mm FF
AD15 73 M Cecum, asc, desc Tubular 
adenoma
Low-grade 12 mm, 10 mm, 
6-8 mm
FF
AD16 64 M Transv, sigmoid, 
rectum
Tubular 
adenoma
Low-grade 5 mm, 25 mm, 
15 mm
FF
AD17 63 M Asc, transv, 
rectum
Tubular 
adenoma
Low-grade 2-3 mm, 5 mm, 
5-6 mm, 15 mm
FF
AD18 63 F Sigmoid Tubulovillous 
adenoma
Low-grade 25 mm FF
AD19 63 M Rectum Tubulovillous 
and tubular 
adenoma
Low-grade 25 mm, 30 mm FF
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DNA was eluted in 2 × 100 μL RNase- and DNase-free 
water and stored at -20 ℃. The quantity of the isolated 
DNA samples was measured by Qubit fluorometer using 
the Qubit dsDNA HS Assay (Invitrogen, ThermoFisher 
Scientific).
Bisulfite-specific PCR and MS-HRM experiments for 
SFRP1 promoter methylation analysis 
Bisulfite conversion was performed using the EZ DNA 
Methylation Direct™ Kit (Zymo Research, Irvine, 
CA, United States) according to the manufacturer’s 
instructions. For fresh frozen samples, 500 ng isolated 
DNA was converted, while for FFPE samples the total 
recovered DNA after deparaffinization and digestion 
was bisulfite converted. Bisulfite-specific PCR (BS-
PCR) reactions were performed in 15 μL volume 
using LightCycler 480 Probes Master (Roche Applied 
Science), LightCycler® 480 ResoLight Dye (Roche), 
SFRP1 primers at 0.2 μmol/L final concentrations and 
bisulfite converted DNA (bcDNA) samples (approx, 5 
ng bcDNA/well). The sequences of the applied SFRP1 
BS-PCR primers were previously described[19]. Real-
time PCR amplification was carried out on LightCycler 
480 System with the following thermocycling con-
ditions: 95 ℃ for 10 min, then 95 ℃ for 30 s, 62 ℃ 
with 0.4 ℃ decreasement/cycle for 30 s, 72 ℃ for 30 s 
for 10 touchdown cycles, followed by the amplification 
at 95 ℃ for 30 s, 58 ℃ for 30 s, and 72 ℃ for 30 s 
in 50 cycles. For HRM calibration, unmethylated and 
methylated bisulfite converted control DNA (EpiTect 
PCR Control DNA Set, Qiagen) were used in different 
ratios (0%, 10%, 25%, 50%, 75% and 100% 
methylated controls). HRM analyis was performed 
according to the following thermal conditions: after 
denaturation at 95 ℃ for 1 min, and cooling at 40 ℃ 
for 1 min, the reactions were continuously warmed 
up to 95 ℃ with a 25 acquisition/℃ rate. Raw HRM 
data were exported and the HRM peak heights of the 
negative derivative of fluorescence over temperature 
curves (-(d/dT) Fluorescence) of the biological sam-
ples were retrieved at the melting temperatures of 
the methylated and unmethylated standards. The 
methylation percent was calculated by the ratio of 
values at the methylated and unmethylated melting 
temperatures. For statistical evaluation normal 
distribution was determined and the applied tests were 
chosen according to the above-mentioned criteria.
SFRP1 immunohistochemistry
Parallel with our epigenetic examinations, 4 nm 
thick FFPE samples from healthy children (n = 6) 
and healthy adults (n = 7) were examined. SFRP1 
immunohistochemistry was performed on colonic 
tissue samples of healthy adults (n = 7; mean age at 
histology examination: 48 ± 17 years; 5 f/2 m) and of 
children (mean age: 12 ± 6 years); 3f/3m). Histology 
was diagnosed by an expert pathologist on routinely 
stained HE sections. Following deparaffinization 
and rehydration, microwave based antigen retrieval 
was performed in TRIS EDTA buffer (pH 9.0) (900 
W/10 min, then 340 W/40 min). Samples were 
immunostained with SFRP1 polyclonal antibody 
(ab4193, Abcam, Cambridge, United Kingdom, 1:80 
dilution) with diaminobenzidine - hydrogen peroxidase - 
chromogen-substrate system (cat#30014.K, HISTOLS-
DAB, Histopathology Ltd., Hungary) and were digitalized 
by Pannoramic 250 Flash II scanner (with Zeiss Plan-
Apochromat 20 × objective; 3DHISTECH Ltd, Hungary). 
Digital slides were semi-quantitatively analyzed with 
Pannoramic Viewer (ver.:1.15.3; 3DHISTECH) based on 
Q-score method (scored by multiplying the percentage 
of positive cells (P) by the intensity (I: +3, +2, +1, 
0). Formula: Q = P × I; Maximum = 300). Epithelial 
and stromal compartments were examined separately, 
then these scores were summarized (Σ) (Σ Q-score 
maximum: 600) in order to have comparable results 
with our whole biopsy methylation analyses.
Statistical analysis
The applied statistical methods are outlined above after 
the descriptions of molecular and in silico analyses. 
The statistical review of the study was performed by a 
biomedical statistician.
RESULTS
Gene ontology of 353 CpG sites of the "epigenetic 
clock"
The “epigenetic clock” signature includes 353 CpG 
sites[2] including different genes, gene promoters and 
AD20 87 M Sigmoid, rectum Tubulovillous 
adenoma
Low-grade 20 mm, 15 mm FF
AD21 63 F Sigmoid Tubulovillous 
adenoma
Low-grade 25 mm FF
CRC1 67 F Sigmoid Adenocarcinoma Unknown Unknown Unknown FF
CRC2 76 F Hepatic flexure Adenocarcinoma T2N0M0 2 B1 FF
CRC3 73 F Sigmoid Adenocarcinoma T3N2M1 2 D FF
CRC4 65 M Sigmoid Adenocarcinoma T2N0M0 1 B1 FF
CRC5 85 F Cecum Adenocarcinoma T2N0M0 2 B1 FF
CRC6 60 M Hepatic flexure Adenocarcinoma unknown D FF
CRC7 68 M Sigmoid, rectum Adenocarcinoma T3N0M0 1 B2 FF
CRC8 87 F Sigmoid Adenocarcinoma T3N0M0 2 B2 FF
Ch: Children; N: Normal; Ad: Adenoma; CRC: Colorectal cancer.
Galamb O et al . Aging related methylation of colorectal cancer linked genes
10330 December 21, 2016|Volume 22|Issue 47|WJG|www.wjgnet.com
other genomic regions such as enhancers, insulators, 
Polycomb-repressed regions. From the above 353 CpG 
sites, DNA methylation levels of 193 were positively 
and of 160 were negatively correlated with age[2]. 
First we updated the annotation of the CpG sites and 
assigned official gene symbols according to the newest 
version of NCBI Gene Database. Approximately 
80% of the genes belonging to 353 CpG sites could 
be classified into functional groups including highly 
represented transcriptional regulation, translation 
(15.93%), metabolism (12.36%), development 
and ontogenesis (8.24%) and transport (8.24%). 
Approximately 20% of the genes had unknown 
function. According to the Encode ChromHMM results 
of nine human cell lines, the majority of the 353 CpG 
sites (76.2 %) were located in the promoter regions 
of genes. Also, 57.2% of them were categorized as 
active promoters (declared if it was found “active 
promoter” in at least one of the nine analyzed cell 
lines), while 19% were found to be “weak promoter” 
(“weak promoter” in at least one of the nine analyzed 
cell lines). One fourth (23.8%) of the CpG sites was 
located in non-promoter regions such as enhancers, 
insulators, transcribed and repressed regions (Supple-
mentary Table 1).
In silico DNA methylation analysis
Analysis of the Illumnina Beadchip450K methylation 
array data set of Luo et al[24] showed 137 (38.8%) 
of the epigenetic clock CpG sites were found to be 
significantly differentially methylated between CRC 
and normal tissue samples (P < 0.05). Approximately 
two third of these CpG sites had similar methylation 
changes in CRC samples as during aging, while one 
third of these CpG sites showed opposite alterations 
in CRC tissue as during aging (Supplementary Table 
1). Among these, 57 CpG sites showed at least 
a 10% methylation difference: from the 57 CpG 
sites 45 were hypermethylated (including ADHFE1/
cg08090772, MCAM/cg21096399, DKK3/cg13216057, 
SFRP1/cg02388150, SYNE1/cg26620959), while 12 
CpG sites showed hypomethylation (such as MGP/
cg00431549, PIPOX/cg06144905, STRA6/cg00075967, 
ERG/cg17274064) in CRCs (P < 0.05, ∆β ≥ 10%) 
(Table 2, Supplementary Table 1). In the adenoma vs 
normal comparison, DNA methylation of 165 CpG sites 
(46.7%) were significantly altered from which 70 CpG 
sites showed a ≥ 10% methylation difference: 36 CpG 
sites were hypermethylated (e.g., SDC2/cg25070637, 
SFRP1/cg02388150, SYNE1/cg26620959) and 34 
showed decreased methylation levels (including 
CEMIP/cg20828084, SPATA18/cg03103192, STRA6/
cg00075967) in adenoma samples (P < 0.05, ∆
β ≥ 10%) (Table 3). In CRC samples 33 CpG sites 
were found to be hypermethylated (such as KRT20/
cg00091693, STRA6/cg00075967, UROS/cg19346193) 
and only one (LTBP3/cg08965235) was hypomethylated 
compared to adenomas (P < 0.05, ∆β ≥ 10%) (Table 4). 
A heatmap for the differentially methylated epigenetic 
clock CpG sites (P < 0.05, ∆β ≥ 10%), with hierarchical 
cluster analysis results of normal, adenoma and CRC 
samples is shown in Figure 1. 
Table 2  Significant DNA methylation alterations of age-
related CpG sites in CRC samples compared to normal tissue
cgID Gene symbol P  value ∆β (CRC - N)
cg06462291 NT5DC3 3.81 × 10-6 -0.27
cg06144905 PIPOX 1.81 × 10-7 -0.22
cg10345936 SLC36A2 2.49 × 10-5 -0.18
cg13828047 MPI 1.78 × 10-5 -0.17
cg11314684 AKT3 4.55 × 10-5 -0.16
cg00431549 MGP 0.020 -0.12
cg14409958 ENPP2 0.021 -0.11
cg00091693 KRT20 0.010 -0.11
cg17274064 ERG 1.48 × 10-4 -0.11
cg22809047 RPL31 1.91 × 10-3 -0.10
cg00075967 STRA6 0.010 -0.10
cg06952310 NCAN 7.13 × 10-3 -0.10
cg02388150 SFRP1 3.33 × 10-3  0.10
cg03588357 GPR68 7.72 × 10-3  0.10
cg26297688 TMEM263 6.21 × 10-3  0.10
cg04528819 KLF14 0.036  0.10
cg26372517 TFAP2E 9.23 × 10-3  0.11
cg08030082 POMC 1.93 × 10-3  0.11
cg05675373 KCNC4 7.80 × 10-3  0.11
cg10281002 TBX5 0.012  0.11
cg06117855 CLEC3B 1.87 × 10-3  0.11
cg09509673 CCR10 1.91 × 10-4  0.11
cg14597908 GNAS 1.48 × 10-4  0.11
cg27494383 LTK 9.32 × 10-3  0.12
cg21870884 GPR25 5.77 × 10-3  0.13
cg25657834 NTSR2 4.43 × 10-3  0.13
cg22449114 TCF15 3.48 × 10-5  0.13
cg04126866 C10orf99 4.52 × 10-4  0.13
cg25552492 LGI3 9.44 × 10-3  0.14
cg08965235 LTBP3 3.12 × 10-3  0.14
cg06836772 PRKAA2 0.013  0.14
cg02364642 ARHGEF25 1.20 × 10-3  0.16
cg18573383 KCNC2 1.38 × 10-3  0.16
cg12616277 ESYT3 0.015  0.16
cg17729667 NINL 3.46 × 10-3  0.16
cg04999691 ZBED6CL  3.32 × 10-11  0.16
cg12373771 CECR6 3.70 × 10-3  0.17
cg02489552 CCDC105 8.91 × 10-8  0.17
cg25148589 GRIA2 7.77 × 10-6  0.19
cg21096399 MCAM 5.47 × 10-6  0.19
cg20914508 GAP43 4.24 × 10-4  0.20
cg12768605 LYPD5 1.85 × 10-4  0.21
cg13216057 DKK3 2.10 × 10-4  0.21
cg12351433 LHCGR 4.97 × 10-7  0.22
cg08434234 DGKI 5.16 × 10-5  0.23
cg10920957 JPH3 3.00 × 10-4  0.26
cg27092035 ARL10 3.73 × 10-5  0.27
cg06557358 TMEM132E 3.17 × 10-6  0.27
cg26620959 SYNE1 1.32 × 10-6  0.30
cg07663789 NPR3 8.73 × 10-6  0.31
cg09191327 PRDM12 1.79 × 10-6  0.31
cg25070637 SDC2 1.64 × 10-6  0.34
cg10486998 GALR1 1.81 × 10-8  0.35
cg24834740 PPP1R16B  3.56 × 10-12  0.37
cg27319898 ZNF804B 5.41 × 10-8  0.38
cg08090772 ADHFE1  7.18 × 10-14  0.39
cg02217159 KHDRBS2  6.67 × 10-13  0.43
N: Normal; CRC: Colorectal cancer.
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In silico gene expression analysis
Genes belonging to 353 age-related CpG sites were 
mapped to 768 Affymerix transcript IDs. In the CRC 
vs N comparison, 215 “epigenetic clock” genes were 
found to be significantly differentially expressed (P < 
0.05), of which 117 were altered with absolute logFC > 
0.5 (70 upregulated such as ERG, MGP, MCAM, CEMIP 
and 47 downregulated like SFRP1, KRT20, CLEC3B, 
SYNE1) (Supplementary Table 2A). Expression of 
196 “epigenetic clock” genes changed significantly (P 
< 0.05) in adenoma samples compared to healthy 
normal controls, 102 with absolute logFC higher than 
0.5 (47 overexpressed such as CEMIP, PLK1, CCNF 
and 55 underexpressed like SFRP1, SDC2, SYNE1) 
(Supplementary Table 2B). Forty-three genes including 
MCAM, MGP and AKT3 showed increased expression in 
Table 3  Significant DNA methylation changes of age-related 
CpG sites in adenoma samples compared to normal tissue
cgID Gene symbol P  value ∆β (AD - N)
cg10345936 SLC36A2  3.49 × 10-10 -0.34
cg00091693 KRT20  2.49 × 10-12 -0.30
cg00075967 STRA6 2.58 × 10-9 -0.26
cg11314684 AKT3 1.03 × 10-9 -0.26
cg06462291 NT5DC3 7.45 × 10-5 -0.25
cg17099569 GLI2  1.25 × 10-10 -0.23
cg00168942 GJD4 2.48 × 10-7 -0.20
cg20828084 CEMIP 1.33 × 10-9 -0.19
cg17274064 ERG  1.82 × 10-10 -0.19
cg07408456 PGLYRP2  2.41 × 10-12 -0.19
cg03019000 TEX264 2.25 × 10-7 -0.19
cg17589341 SLC14A1 1.42 × 10-9 -0.19
cg02580606 KRT33B 9.08 × 10-5 -0.17
cg00436603 CYP2E1 1.37 × 10-8 -0.16
cg19346193 UROS 6.59 × 10-7 -0.15
cg03103192 SPATA18 1.39 × 10-7 -0.15
cg25564800 KPNA1 2.18 × 10-8 -0.14
cg06144905 PIPOX 3.63 × 10-7 -0.14
cg06952310 NCAN 2.72 × 10-4 -0.14
cg13038560 C2orf47 2.13 × 10-5 -0.13
cg22190114 NLRP8 1.67 × 10-4 -0.13
cg13302154 MGP 7.27 × 10-6 -0.13
cg01262913 DSCR9 2.67 × 10-6 -0.13
cg14258236 OR5V1 3.71 × 10-4 -0.12
cg13828047 MPI 1.01 × 10-3 -0.12
cg01459453 SELP 1.65 × 10-4 -0.12
cg14894144 LAMA3 2.29 × 10-4 -0.12
cg07337598 ANXA9 2.02 × 10-5 -0.12
cg03270204 DDR1 7.47 × 10-5 -0.12
cg12946225 HMG20B 1.37 × 10-6 -0.11
cg09646392 TNFSF13B 2.66 × 10-5 -0.10
cg19305227 SLC28A2 0.033 -0.10
cg03578041 LARP6 2.22 × 10-5 -0.10
cg07455279 NDUFA3 0.013 -0.10
cg13899108 PDE4C 5.00 × 10-6  0.10
cg04999691 ZBED6CL 4.92 × 10-5  0.10
cg14597908 GNAS 9.38 × 10-5  0.10
cg21870884 GPR25 9.49 × 10-3  0.11
cg12616277 ESYT3 0.022  0.12
cg12373771 CECR6 3.55 × 10-3  0.12
cg17729667 NINL 4.43 × 10-3  0.13
cg02364642 ARHGEF25 2.33 × 10-3  0.14
cg22449114 TCF15 2.39 × 10-5  0.14
cg03565323 ZNF287 4.52 × 10-3  0.14
cg02388150 SFRP1 1.20 × 10-7  0.15
cg12768605 LO×L2 8.01 × 10-3  0.15
cg25657834 NTSR2 1.46 × 10-4  0.16
cg20914508 GAP43 9.41 × 10-4  0.16
cg10281002 TBX5 1.26 × 10-5  0.17
cg02489552 CCDC105 7.16 × 10-8  0.18
cg05675373 KCNC4 1.82 × 10-6  0.18
cg25148589 GRIA2 6.11 × 10-7  0.18
cg13216057 DKK3 9.64 × 10-4  0.18
cg27092035 ARL10 8.81 × 10-4  0.19
cg12351433 LHCGR 2.20 × 10-6  0.20
cg18573383 KCNC2 5.43 × 10-7  0.21
cg08434234 DGKI 6.60 × 10-5  0.22
cg21096399 MCAM 5.20 × 10-8  0.22
cg10920957 JPH3 1.03 × 10-4  0.25
cg08965235 LTBP3  6.03 × 10-10  0.25
cg27319898 ZNF804B 5.48 × 10-5  0.26
cg26620959 SYNE1 3.89 × 10-6  0.29
cg25070637 SDC2 1.82 × 10-5  0.30
cg07663789 NPR3 6.41 × 10-7  0.31
cg09191327 PRDM12 4.08 × 10-7  0.31
cg06557358 TMEM132E 2.04 × 10-8  0.33
cg10486998 GALR1 2.61 × 10-9  0.36
cg24834740 PPP1R16B 2.23 × 10-9  0.36
cg08090772 ADHFE1  5.19 × 10-11  0.39
cg02217159 KHDRBS2  1.87 × 10-11  0.41
N: Normal; Ad: Adenoma.
Table 4  Significant DNA methylation alterations of age-
related CpG sites in colorectal cancer samples compared to 
adenoma tissue
cgID Gene symbol P  value ∆β (CRC - AD)
cg08965235 LTBP3 9.09 × 10-4 -0.11
cg00945507 SEC61G 1.64 × 10-5  0.10
cg15974053 HSD17B14 2.27 × 10-3  0.10
cg24262469 TIPARP 5.33 × 10-8  0.10
cg07158339 FXN 1.84 × 10-7  0.10
cg11314684 AKT3 4.52 × 10-4  0.10
cg03578041 LARP6 2.57 × 10-9  0.10
cg17853587 NDST3 5.94 × 10-4  0.10
cg07408456 PGLYRP2 1.51 × 10-7  0.11
cg02580606 KRT33B 1.22 × 10-4  0.11
cg03019000 TEX264 5.39 × 10-5  0.11
cg27319898 ZNF804B 0.023  0.12
cg00436603 CYP2E1 1.97 × 10-6  0.12
cg15804973 MAP3K5  6.27 × 10-12  0.12
cg06117855 CLEC3B 1.73 × 10-7  0.13
cg24126851 DCHS1 3.58 × 10-8  0.13
cg16034652 UNC79  4.23 × 10-11  0.13
cg01262913 DSCR9 1.64 × 10-8  0.13
cg26372517 TFAP2E 9.80 × 10-6  0.13
cg03270204 DDR1 4.24 × 10-7  0.13
cg17589341 SLC14A1  7.35 × 10-10  0.13
cg22679120 SNX8 8.16 × 10-9  0.14
cg20828084 CEMIP 2.00 × 10-8  0.14
cg19305227 SLC28A2 1.11 × 10-6  0.14
cg00168942 GJD4 1.18 × 10-7  0.14
cg13038560 C2orf47 8.96 × 10-8  0.15
cg26614073 SCAP 1.33 × 10-9  0.15
cg19346193 UROS 2.09 × 10-8  0.16
cg00075967 STRA6 4.87 × 10-7  0.16
cg03103192 SPATA18  6.07 × 10-12  0.16
cg10345936 SLC36A2 4.09 × 10-6  0.16
cg17099569 GLI2 9.04 × 10-7  0.16
cg04126866 C10orf99  4.23 × 10-10  0.18
cg00091693 KRT20 1.17 × 10-8  0.19
N: Normal; Ad: Adenoma; CRC: Colorectal cancer.
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CRC compared to adenoma samples, while 17 genes 
including CEMIP, SPATA18 were downregulated (P < 
0.05, absolute logFC > 0.5) (Supplementary Table 2C). 
For genes with an inverse relation between gene 
expression and promoter methylation, the genes 
with both significant mRNA expression changes with 
absolute logFC > 0.5 and significant DNA methylation 
alterations with at least 10% difference were taken into 
consideration. Based on these criteria, eleven genes, 
including ERG, MGP, PIPOX, CLEC3B, LTK, SFRP1 and 
SYNE1 were found to be inversely expressed with 
the promoter methylation status in CRC compared to 
normal tissue. Compared to the promoter methylation 
alterations, the expression of 8 genes, including 
CEMIP, SPATA18, SDC2, SFRP1 and SYNE1 changed 
oppositely in AD vs N comparison, while in CRC vs 
AD tissues 3 genes, namely CEMIP, SPATA18 and 
SLC28A2 showed this expression pattern. The genes 
showing an inverse relation between gene expression 
and DNA methylation in CRC vs normal, AD vs normal 
and CRC vs AD comparisons are represented in Table 5.
In the comparison of healthy young colonic 
samples and normal adult tissues, 150 genes showed 
significantly altered expression from which 94 genes 
with absolute logFC > 0.5 including overexpressed 
LTBP3, REEP1, MGP, PLK1, SFRP1, SYNE1 and 
downregulated PRKG2, PDCD6IP and TMEM56 (P 
< 0.05) (Supplementary Table 2D). The pattern of 
expression of several genes including SYNE1, CLEC3B, 
LTBP3 (Figure 2) and SFRP1 (Figure 3A-C) was 
similar for increased age as that observed for cancer 
progression. However, there were some genes such 
as MGP (Figure 2) which showed similar expression 
pattern in young people and in cancer patients 
compared to healthy adult tissue.
Whole promoter methylation status of genes showing 
inverse relationship between gene expression and DNA 
methylation 
The DNA methylation status of whole promoter 
regions of genes showing an inverse relation between 
gene expression and DNA methylation (Table 5) was 
determined using methyl capture sequencing data of 6 
NAT, 15 adenoma and 9 CRC tissue samples[12]. In the 
CRC vs N/NAT comparison, similar DNA methylation 
alterations (such as hypomethylated AKT3, MGP 
promoters and hypermethylated PPP1R16B, SFRP1, 
SYNE1 promoters) were observed in the promoter 
regions of 7 of the 11 inversely expressed genes 
(Table 6). Between adenoma and normal samples, 
promoter regions of 7 of the 8 inversely expressed 
genes showed DNA methylation differences (e.g., 
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Figure 1  DNA methylation heatmap of normal, adenoma and colorectal carcinoma samples according to the methylation status of age-related CpG 
sites. From the 353 epigenetic clock CpG sites (cg IDs)[2] significantly differentially methylated in CRC vs normal, adenoma vs normal and CRC vs adenoma 
comparisons were selected and colonic tissue samples (GSE48684[24]) were classified according to their methylation levels. The analyzed samples are illustrated on 
X axis, significantly altered CpG sites (cg IDs) are represented on Y axis. DNA methylation intensities (β values) are visualized, red shows hypermethylation, while 
hypomethylation was marked with green color. CRC: Colorectal carcinoma (light green); Ad: Adenoma (dark blue); N: Normal (light blue).
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hypomethylated CEMIP/KIAA1199, SPATA18 pro-
moters and hypermethylated DKK3, SDC2, SFRP1, 
SYNE1 promoters) (Table 6) as detected in case of 
age-related CpG sites. In CRC samples compared 
to adenoma tissue, significant hypermethylation of 
CEMIP/KIAA199 promoter could be demonstrated 
in “epigenetic clock” CpG sites and whole promoter 
methylation analyses (Table 6). 
SFRP1 promoter methylation analysis in healthy 
children, healthy adult, adenoma and CRC tissues
Based on the gene expression analysis results, SFRP1 
was found to be overexpressed in normal adult samples 
compared to adenoma and CRC biopsy specimens, and 
in healthy young patients even higher SFRP1 mRNA 
levels could be detected than in normal adult samples 
(Figure 3A-C). As SFRP1 is proven to be a methylation-
regulated gene with literature data regarding its age-
related DNA methylation alterations, hence it was 
chosen for detailed methylation analysis of normal, 
premalignant and cancerous colonic specimens including 
tissue samples from healthy children.
SFRP1 promoter sequences were highly methylated 
in CRC samples (average methylation% = 55.0% ± 
8.4%) and in adenoma tissue (49.9% ± 18.1 %), 
while low methylation levels could be measured in 
colonic tissues of both healthy adults (5.2% ± 2.7%) 
and children (2.2% ± 0.7%). Significant considerable 
hypermethylation was found in SFRP1 promoter both 
between CRC and adult normal and between CRC 
and healthy children colonic tissue samples (P < 
0.0001) (Figure 3D). In the healthy adult vs healthy 
children comparison, significant, but moderate DNA 
methylation alterations were detected: in adults higher 
DNA methylation levels were found in the analyzed 
region of SFRP1 promoter (P = 0.017) (Figure 3E). 
SFRP1 protein expression in colonic tissue samples of 
healthy normal children and adults
In healthy children samples the epithelial layer showed 
strong (representative scoring values: +3 and +2), 
diffuse SFRP1 expression both in cytoplasmic and 
nuclear region (Q-score: 226.67 ± 17.51), whereas 
the stromal cells showed heterogeneous protein 
expression (scoring values: form +3 to 0; Q-score: 
176.66 ± 18.61; ΣQ-score: 403.33 ± 22.51; Figure 
4A). Among stromal cells subepithelial fibroblast and 
several immune cells showed strong cytoplasmic 
Figure 2  Genes showing both age- and carcinogenesis-related expression alterations. SYNE1 (spectrin repeat containing nuclear envelope protein 1), LTBP3 
(latent transforming growth factor beta binding protein 3) and CLEC3B (C-type lectin domain family 3 member B) genes were downregulated during the colorectal 
carcinogenesis, similar decreasing expression was found during aging (significantly higher mRNA levels were detected in young colonic samples than in healthy 
adult biopsy specimens). MGP (matrix Gla protein) was overexpressed in children and in CRC samples compared to adenoma and healthy adults (P < 0.035), hence 
its opposite expression was found during aging and colorectal carcinogenesis. X axis shows the analyzed sample groups, the normalized mRNA expression can be 
seen on Y axis. Red dots indicate the normalized mRNA expression values, boxplots represent the medians and standard deviations. Ch: Children; N: Normal; Ad: 
Adenoma; CRC: Colorectal cancer.
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and/or nuclear SFRP1 expression. Not significantly, 
but remarkably lower (representative scoring value: 
+2) SFRP1 protein expression was detectable both 
in epithelial (Q-score: 202.14 ± 24.12) and stromal 
component (140.71 ± 41.47; Σ Q-score: 351.42 ± 
68.66; Figure 4B) of adult persons (P values: 0.063, 
0.073 and 0.105 respectively).  
DISCUSSION
Cancer is considered a primary age-related disease[3], 
and therefore age-related molecular changes including 
epigenetic alterations such as epigenetic drift and 
epigenetic clock[1,2] necessarily show relationship 
with carcinogenesis-associated differences. Besides 
global hypomethylation, local, genomic site specific 
hypermethylation principally in the promoter regions 
of tumor suppressor genes can occur during both 
processes[6-8]. 
In this study, the potential correspondence 
between age-related and CRC-associated DNA 
methylation changes was studied using the 353 
epigenetic clock CpG sites published by Horvath[2] as 
a model for age-related DNA methylation changes. 
Table 5  Genes showing inverse DNA methylation and gene expression data
Gene symbol Gene name DNA methylation Gene expression
cg ID P  value ∆β Affymetrix ID P  value LogFC
CRC vs N
   AKT3 AKT serine/threonine kinase 3 cg11314684 4.55 × 10-5 -0.16 224229_s_at 0.015  0.07
222880_at 2.26 × 10-3  0.61
212609_s_at 4.72 × 10-4  0.62
212607_at 9.76 × 10-4  0.64
   ERG v-ets avian erythroblastosis virus E26 
oncogene homolog
cg17274064 1.48 × 10-4 -0.11 211626_x_at 5.84 × 10-4  0.20
241926_s_at 2.05 × 10-5  0.64
213541_s_at 4.69 × 10-9  1.08
   MGP Matrix Gla protein cg00431549 0.020 -0.12 202291_s_at  2.34 × 10-11  1.97
   PIPOX Pipecolic acid and sarcosine oxidase cg06144905 1.81 × 10-7 -0.22 221605_s_at 0.019  0.50
   CCR10 C-C motif chemokine receptor 10 cg09509673 1.91 × 10-4  0.11 220565_at 0.010 -0.51
   CLEC3B C-type lectin domain family 3 member 
B
cg06117855 1.88 × 10-3  0.11 205200_at  1.45 × 10-13 -1.79
   LTK Leukocyte receptor tyrosine kinase cg27494383 9.32 × 10-3  0.12 217184_s_at  2.14 × 10-11 -1.32
207106_s_at 2.00 × 10-5 -0.75
   PPP1R16B Protein phosphatase 1 regulatory 
subunit 16B
cg24834740  3.56 × 10-12  0.37 41577_at 1.76 × 10-4 -0.79
212750_at 7.68 × 10-3 -0.48
   PRKAA2 Protein kinase AMP-activated catalytic 
subunit alpha 2
cg06836772 0.013  0.14 227892_at 4.15 × 10-3 -0.87
238489_at 4.67 × 10-3 -0.22
   SFRP1 Secreted frizzled related protein 1 cg02388150 3.33 × 10-3  0.10 202036_s_at 8.66 × 10-8 -1.47
202037_s_at 3.98 × 10-5 -1.11
202035_s_at 0.039 -0.28
   SYNE1 Spectrin repeat containing nuclear 
envelope protein 1
cg26620959 1.32 × 10-6  0.30 209447_at 4.27 × 10-5 -0.63
AD vs N
   CEMIP Cell migration inducing hyaluronan 
binding protein
cg20828084 1.33 × 10-9 -0.17 1554685_a_at  1.71 × 10-11  1.12
212942_s_at  2.41 × 10-43  6.88
   NT5DC3 5'-nucleotidase domain containing 3 cg06462291 7.45 × 10-5 -0.25 218786_at 6.83 × 10-9  0.76
   SPATA18 Spermatogenesis associated 18 cg03103192 1.39 × 10-7 -0.15 230723_at 4.41 × 10-5  0.45
229331_at  1.20 × 10-10  1.50
   DKK3 Dickkopf WNT signaling pathway 
inhibitor 3
cg13216057 9.64 × 10-4  0.18 202196_s_at 9.82 × 10-5 -0.65
214247_s_at 1.52 × 10-4 -0.50
   PPP1R16B Protein phosphatase 1 regulatory 
subunit 16B
cg24834740 2.23 × 10-9  0.36 41577_at  1.20 × 10-10 -1.44
212750_at 3.28 × 10-7 -0.81
   SDC2 Syndecan 2 cg25070637 1.82 × 10-5  0.30 212158_at  1.74 × 10-10 -1.17
212157_at 2.14 × 10-8 -0.66
212154_at 9.19 × 10-5 -0.64
   SFRP1 Secreted frizzled related protein 1 cg02388150 1.20 × 10-7  0.15 202036_s_at  3.62 × 10-13 -1.79
202037_s_at  4.43 × 10-11 -1.48
202035_s_at 0.016 -0.32
   SYNE1 Spectrin repeat containing nuclear 
envelope protein 1
cg26620959 3.89 × 10-6  0.29 209447_at  5.76 × 10-15 -1.19
CRC vs AD
   CEMIP Cell migration inducing hyaluronan 
binding protein
cg20828084 2.00 × 10-8  0.14 212942_s_at 9.88 × 10-3 -1.17
   SLC28A2 Solute carrier family 28 member 2 cg19305227 1.11 × 10-6  0.14 207249_s_at 0.027 -1.24
   SPATA18 Spermatogenesis associated 18 cg03103192  6.07 × 10-12  0.16 229331_at 3.52 × 10-9 -1.73
230723_at 7.35 × 10-4 -0.41
N: Normal; Ad: Adenoma; CRC: Colorectal cancer.
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Table 6  Whole promoter methylation status of genes with inverse age-related CpG site DNA methylation and gene expression data 
Gene symbol DNA methylation on age-related CpG site Whole promoter DNA methylation status
cg ID P  value ∆β Start-Stop position P  value ∆β
CRC vs N
   AKT3 cg11314684 4.55 × 10-5 -0.16 chr1:244005801-244005900 6.56 × 10-3 -0.33
   ERG cg17274064 1.48 × 10-4 -0.11 chr21:39871501-39871600 0.044 -0.21
   MGP cg00431549 0.020 -0.12 chr12:15038501-15038600 0.030 -0.27
   CCR10 cg09509673 1.91 × 10-4  0.11 chr17:40835101-40835200 0.045  0.18
chr17:40835201-40835300 0.022  0.26
   PPP1R16B cg24834740  3.56 × 10-12  0.37 chr20:37433201-37433300 3.76 × 10-3  0.35
chr20:37434701-37434800 0.048  0.40
chr20:37435301-37435400 0.042  0.37
   SFRP1 cg02388150 3.33 × 10-3  0.10 chr8:41166001-41166100 0.017  0.44
chr8:41166101-41166200 1.31 × 10-4  0.56
chr8:41166201-41166300 3.40 × 10-3  0.49
chr8:41166301-41166400 0.014  0.27
chr8:41166401-41166500 1.28 × 10-3  0.53
chr8:41166501-41166600 0.027  0.44
chr8:41166601-41166700 0.034  0.39
chr8:41166901-41167000 0.042  0.41
   SYNE1 cg26620959 1.32 × 10-6  0.30 chr6:152622201-152622300 0.027  0.35
chr6:152957601-152957700 0.032  0.39 
chr6:152957701-152957800 0.043  0.40
chr6:152958101-152958200 2.86 × 10-4  0.65
AD vs N
   CEMIP cg20828084 1.33 × 10-9 -0.17 chr15: 81070701-81070800 0.028 -0.25
   SPATA18 cg03103192 1.39 × 10-7 -0.15 chr4:52915901-52916000 0.042 -0.23
   DKK3 cg13216057 9.64 × 10-4  0.18 chr11:12029701-12029800 3.11 × 10-3  0.26
chr11:12029801-12029900 1.67 × 10-3  0.33
chr11:12029901-12030000 8.08 × 10-5  0.56
chr11:12030001-12030100 0.047  0.15
chr11:12030401-12030500 7.38 × 10-3  0.28
chr11: 12030501-12030600 0.012  0.28
   PPP1R16B cg24834740 2.23 × 10-9  0.36 chr20:37434201-37434300 0.045  0.26
chr20:37434601-37434700 0.022  0.39
chr20:37434701-37434800 0.013  0.39
chr20:37434801-37434900 6.87 × 10-3  0.30
chr20:37434901-37435000 1.70 × 10-3  0.44
chr20:37435001-37435100 1.93 × 10-3  0.45
chr20:37435101-37435200 6.49 × 10-3  0.35
chr20:37435201-37435300 8.93 × 10-4  0.51
chr20:37435301-37435400 0.014  0.42
   SDC2 cg25070637 1.82 × 10-5  0.30 chr8:97505901-97506000 2.30 × 10-3  0.59
chr8:97506101-97506200 1.96 × 10-4  0.65
chr8:97506201-97506300 8.43 × 10-4  0.63
chr8:97506301-97506400 0.012  0.49
chr8:97506401-97506500 0.019  0.47
chr8:97506601-97506700 3.99 × 10-3  0.51
chr8:97506701-97506800 0.021  0.45
chr8:97506801-97506900 0.014  0.52
chr8:97507101-97507200 0.015  0.44
chr8:97507201-97507300 0.010  0.52
chr8:97507301-97507400 3.47 × 10-3  0.59
   SFRP1 cg02388150 1.20 × 10-7  0.15 chr8:41165901-41166000 2.30 × 10-3  0.59
chr8:41166001-41166100 1.57 × 10-3  0.59
chr8:41166101-41166200 3.54 × 10-4  0.56
chr8:41166201-41166300 1.49 × 10-4  0.60
chr8:41166301-41166400 6.54 × 10-3  0.27
chr8:41166401-41166500 1.32 × 10-5  0.55
chr8: 41166501-41166600 2.30 × 10-3  0.60
chr8:41166601-41166700 5.45 × 10-3  0.57
chr8:41166701-41166800 8.15 × 10-3  0.51
chr8:41166801-41166900 0.032  0.39
chr8:41166901-41167000 0.019  0.45
chr8:41167001-41167100 0.046  0.34
chr8:41167101-41167200 0.025  0.41
chr8:41167201-41167300 0.024  0.40
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With the analysis of methyl capture sequencing and 
Illumina BeadChip450K methylation array data, the 
methylation status of age-related CpG sites and 
genes was determined during CRC development 
and progression, and the relevant mRNA expression 
changes were also evaluated. Among the differentially 
methylated/expressed age-related genes, SFRP1 
promoter methylation was further analyzed in healthy, 
premalignant and cancerous colonic tissue samples, 
including biopsy specimens from young children.
Similarly to previous findings[29], DNA methylation 
alterations in a considerable proportion of age-related 
CpG sites/gene promoters (approximately 40%) were 
observed in samples representing different stages of 
CRC formation and progression. Approximately two 
third of these CpG sites had similar DNA methylation 
alterations in CRC compared to normal tissue samples 
as during aging. When the effect of DNA methylation 
of epigenetic clock genes was studied, whole promo-
ter methylation was also observed in addition to the 
   SYNE1 cg26620959 3.89 × 10-6  0.29 chr6:152702701-152702800 0.012  0.20
chr6:152702801-152702900 0.035  0.21
chr6:152957501-152957600 6.05 × 10-4  0.37
chr6:152957601-152957700 2.34 × 10-4  0.60
chr6:152957701-152957800 0.017  0.51
chr6:152957801-152957900 1.09 × 10-3  0.42
chr6:152957901-152958000 1.03 × 10-4  0.57
chr6:152958001-152958100 7.13 × 10-4  0.43
chr6:152958101-152958200 1.72 × 10-5  0.72
CRC vs AD
   CEMIP cg20828084 2.00 × 10-8  0.14 chr15:81070701-81070800 7.59 × 10-4  0.31 
chr15:81070801-81070900 0.011  0.36
Only significant promoter DNA methylation alterations are represented in the table. P < 0.05.
Figure 3  SFRP1 mRNA expression and promoter DNA methylation alterations during aging and in different stages of colorectal carcinogenesis. 
SFRP1 mRNA expression was significantly downregulated in adenoma and CRC samples compared to normal controls in case of all three Affymetrix probeset IDs 
representing SFRP1 [202035_s_at: P < 0.05 (A); 202036_s_at: P < 0.0003 (B); 202037_s_at: P < 0.005 (C)]. In colonic biopsy samples of healthy young patients, 
higher SFRP1 mRNA levels could be measured than in normal adults samples, this overexpression was proven to be significant in two of three transcript IDs 
[202035_s_at: P < 0.05 (A); 202037_s_at: P < 0.005 (C)]. SFRP1 promoter region was significantly hypermethylated in CRC and adenoma tissue samples compared 
to normal adult and young colonic tissue (P < 0.0001) (D). In pairwise comparison, DNA methylation of SFRP1 promoter was slightly, but significantly increased in 
healthy adults compared to normal young samples (P < 0.02) (E). The analyzed sample groups are illustrated on X axis, the normalized mRNA expression (A, B, 
C) and percentage of SFRP1 promoter methylation (D, E) are represented on Y axis. Red dots indicate the normalized mRNA expression values (A, B, C) and the 
normalized DNA methylation percentage values (D, E), respectively. Boxplots represent the medians and standard deviations. Ch: Children; N: Normal; Ad: Adenoma; 
CRC: Colorectal cancer.
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analysis of DNA methylation status of representing 
age-related CpG sites.
In accordance with our results, hypermethylation 
of several genes belonging to aging-associated CpG 
sites such as SFRP1[7,12,15,18-23], TFAP2E[30], TBX5[31], 
GNAS[32], DKK3[18,33], DGKI[34], SYNE1[35-37], SDC2[38,39], 
ADHFE1[40-42] was observed in tissue and/or blood 
samples of CRC patients. SFRP1 tumor suppressor 
protein with a putative Wnt-binding site impedes the 
frizzled ligand - Wnt receptor interaction. Its reduced 
expression caused by promoter hypermethylation 
can lead to constitutive activation of Wnt pathway 
which is best characterized signaling pathway in CRC 
pathogenesis[7,12,15,18-23,43]. Worthley et al[15] showed 
strong positive correlation between SFRP1 methylation 
and age (Spearmen’s rank P = 0.72, P < 0.0001) on 
a set of 166 CRC tissue samples from adults [median 
age: 61.2 years (22.8-89.2 years)]. In this study, 
the increase of SFRP1 methylation during the aging 
was also observed, moreover to our best knowledge, 
we provide the first evidence of significantly lower 
SFRP1 methylation levels in children (under 18 years) 
compared to healthy adult colonic tissues. Preliminary 
results of methylation-sensitive restriction enzyme 
methylation array analysis of our reseach groups 
suggested SFRP1 hypomethylation in young colonic 
tissue samples, though the high standard deviations 
of methylation percentages and the low samples size 
limited our conclusions[18]. In accordance with the DNA 
methylation data, elevated mRNA and protein levels 
could be detected in colonic tissues of normal children 
compared to adults.
Dickkopf Wnt signaling pathway inhibitors including 
DKK3 are also frequent targets of epigenetic silencing 
in gastrointestinal tumors promoting carcinogenesis by 
loss of/reduction their expression[33]. Hypermethylated 
syndecan 2 (SDC2) is a potential biomarker for early 
CRC detection both in serum and tissue, although the 
gene silencing effect of elevated promoter methylation 
is not unambiguous according to the literature data[44], 
moreover some observations support its tumorigenic 
activity in CRC[45]. Hypermethylation of spectrin repeat 
containing nuclear envelope protein 1 (SYNE1) suggests 
its tumor suppressor function in CRC[37], which was 
detected not only in CRC tissue samples[35,36], but it 
appears to be a promising marker for blood-based CRC 
detection[37]. Alcohol dehydrogenase, iron containing 
1 (ADHFE1) promoter hypermethylation was found to 
be associated with CRC differentiation[41], furthermore 
it is involved in cell proliferation induction by alcohol in 
colon carcinoma cells[46].
In the case of some genes like AKT3, CEMIP and 
DDR1, promoter hypomethylation was observed in 
different types of cancers such as breast cancer, lung 
cancer and CRC[47-49]. PI3K/Akt pathway is thought 
to be the most commonly activated intracellular 
signaling pathway in human malignancies[50]. AKT 
kinases including AKT3 are remarkable contributors 
to malignant diseases as they are involved in the 
regulation of cell proliferation, growth and survival[50,51]. 
Hypomethylation and overexpression of the cell 
migration-inducing protein (CEMIP/KIAA1199) 
was previously described in CRC[49,52]. In our study, 
hypomethylation of this gene could be detected mainly 
in adenoma samples, however a slight but significant 
decrease in methylation level was observed in CRC 
samples compared to normal controls. In accordance 
with the methylation data, strong upregulation of 
CEMIP mRNAs was shown both in adenoma and CRC 
samples with higher expression values in adenoma 
tissue[53,54]. Due to its robust overexpression at mRNA 
and also at protein levels, CEMIP is considered as a 
candidate prognostic marker for CRC and a potential 
therapeutic target[55]. CEMIP facilitates colon cancer 
cell proliferation via enhancing Wnt signaling[49] and 
promotes tumor growth[55] and cancer dissemination 
under hypoxic conditions[56].
In conclusion, our results regarding DNA me-
thylation alterations of age-related, epigenetic clock 
genes during colorectal carcinogenesis supports 
the concept that aging is one of the main factors 
predisposing cancer including CRC. Several age-
Figure 4  SFRP1 protein expression in colonic tissue samples of healthy normal children and adults. Strong/moderate cytoplasmic and nuclear SFRP1 
expression both in epithelial and stromal compartments of healthy children (A) and healthy adult (B) samples. Digital microscopic images; magnification × 40; scale: 
50 μm. 
A B
50 μm50 μm
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related DNA methylation alterations could be observed 
during development and progression of CRC affecting 
the mRNA expression of certain CRC- and adenoma-
related key control genes. The main CRC-associated 
signal transduction pathways, such as WNT signaling 
and PI3K/Akt pathways are also influenced during 
aging. 
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